Results 61 to 70 of about 15,463 (218)

Synthesis and characterization of some new 4-heteroaryl quinazoline and fused triazolo quinazoline derivatives

open access: yes, 2016
Treatment of chloroquinazoline (2) with primary amines (2-aminothiazoles and sulpha drugs) and secondary amines (morpholine, piperidine, and piperazine) furnished 4-substituted aminoquinazolines (3a,b and 4a,b), 4-aryl quinazolines (5a,b), and ...
El-Badry, Yaser Abdel-Moemen   +2 more
core   +1 more source

A Role for Janus Cyclohexyl Ring Motifs in Medicinal Chemistry. Incorporation Into G‐Quadruplex Ligands and Anti‐Trypanosoma brucei Activity

open access: yesChemBioChem, Volume 27, Issue 21, 12 November 2026.
Naphthalene diimide (NDI) cores with peripheral fluorocyclohexyl ring systems are explored binding to G‐quadruplex DNA and were also assayed against the Trypanosoma brucei parasite. The most active compound of the series displayed nanomolar activity and suggested electrostatic interactions between the polarized cyclohexane and G‐Quad DNA.
Josephine M. Stewart   +7 more
wiley   +1 more source

Synthesis and Evaluation of 2,4-Disubstituted Quinazoline Derivatives with Potent Anti-Angiogenesis Activities

open access: yesMolecules, 2014
A series of 2,4-disubstituted quinazoline derivatives were designed and synthesized. The biological results showed that most of quinazoline derivatives exhibited potent antiproliferative activities against a panel of three tumor cell lines and a good ...
Guangjin Yu   +3 more
doaj   +1 more source

Nanocatalyzed Synthetic Approach for the Quinazolinone and Quinazoline Derivatives: A Review (2015 – Present) [PDF]

open access: yes, 2023
Due to their diverse chemical reactivities and essential range of biological action, quinazolines and their derivatives rank among the most significant heterocyclic compounds.
Lav Kush Kumar Vishwakarma   +3 more
core   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, Volume 20, Issue 11, Page 2741-2763, November 2026.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Acid‐Free, Room‐Temperature Carbamoylations of Heteroaromatics With N‐Substituted Formamides via TBADT Catalysis and Hydrogen Bonding

open access: yesChemistry–Methods, Volume 6, Issue 11, November 2026.
TBAB boost the TBADT catalyzed carbamoylations of heteroaromatics with N‐substituted formamides through halogen─hydrogen bonding network. TBADT‐catalyzed carbamoylation under heat‐free neutral conditions has been reported. Unlike conventional reports, the addition of TBAB, which could promote the TBADT catalytic system via bromide─hydrogen bonding ...
Ziheng Yu   +8 more
wiley   +1 more source

Structure based design and anti-breast cancer evaluation of some novel 4-anilinoquinazoline derivatives as potential epidermal growth factor receptor inhibitors

open access: yesResearch in Pharmaceutical Sciences, 2018
Quinazoline is one of the most widespread scaffolds amongst natural and synthetic bioactive compounds. Recently the quinazoline derivatives and in particular the 4-anilinoquinazolines have attracted much attention for their anticancer properties due to ...
Zahra Haghighijoo   +5 more
doaj   +1 more source

Quinazoline Marketed drugs [PDF]

open access: yes, 2015
Quinazoline is the main six-membered heterocyclic ring system reported for their biological activities, compounds with multiple pharmacophores, which bring together knowledge of a target with understanding of the molecule types that might interact with ...
Palanirajan Vijayaraj Kumar, Theivendren Panneer Selvam,
core  

Pharmacokinetic and Pharmacodynamic Interactions Between Anti‐Asthma Drugs and Medicinal Plants: A Comprehensive Review

open access: yesPhytotherapy Research, Volume 40, Issue 11, Page 6418-6449, November 2026.
ABSTRACT Asthma affects 260–300 million people worldwide. About 20%–35% of patients use medicinal plants with their asthma medication, often without telling their clinicians. Disclosure rates are low; up to 42% of asthma outpatients use herbal products, with no records in their charts.
Emine Kocyigit   +5 more
wiley   +1 more source

Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021–Present)

open access: yesMolecules
Cancer is a complicated, multifaceted disease that can impact any organ in the body. Various chemotherapeutic agents have a low selectivity and are very toxic when used alone or in combination with others.
Heba T. Abdel-Mohsen   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy